Intuitive Surgical (ISRG)

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Luc...

Intuitive Surgical is a leader in surgical robotics, and the stock has a history of deep drawdowns.

Intuitive Surgical (NASDAQ:ISRG) reported a solid second quarter of 2026, with management pointing to continued global adoption of its da Vinci, da Vinci SP and Ion platforms, even as U.S. procedure growth moderated and China remained challenging. Chief Executive Officer Dave Rosa said total proced

Intuitive Surgical (NASDAQ:ISRG) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. Benzinga APIs provide real-time access to earnings call transcripts and

Medical technology company Intuitive Surgical (NASDAQ:ISRG) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 18.5% year on ye...

Johnson & Johnson's post-earnings pullback follows a revenue and EPS beat, raised guidance, and analyst price target increases, with talc litigation remaining the key risk to watch.

The robotic surgery company has posted earnings beats in its past four quarters. Can it make it five in a row?

And Goldman Sachs may be right.

Medical technology company Intuitive Surgical (NASDAQ:ISRG) will be reporting results this Thursday afternoon. Here’s what investors should know. Intuitive S...

Intuitive Surgical's stock has fallen sharply in 2026, but that is more a function of investor sentiment than of the company.

Intuitive Surgical (NASDAQ: ISRG) to report Q2 earnings on July 16. Analysts expect $2.50 EPS and $2.82B revenue. Recent analyst ratings and stock outlook. #ISRG #earnings

Good medical care will always be in high demand, which makes some healthcare stocks strong long-term picks.

The company has the elements that make a fantastic long-term investment.

Intuitive Surgical has faced margin pressure before and bounced back.

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the surgical equipment & consumables - spe...

In this month’s Mailbag, Fools write in about market caps, parenting, AI, adding to winning investments, and what can happen when decades of patient investing quietly compound into opportunities to help others.